Prognostic Role of Inflammatory Indices and Real-World Outcomes in HER2-Positive Metastatic Breast Cancer Treated with Trastuzumab Emtansine

<b><i>Background and Objectives:</i></b> Reliable pretreatment biomarkers to guide treatment selection in HER2-positive metastatic breast cancer (mBC) remain an unmet need. Systemic inflammatory indices derived from routine blood tests have emerged as accessible prognostic markers. This study evalua...

Ful tanımlama

Kaydedildi:

Detaylı Bibliyografya
Asıl Yazarlar:	Taliha Güçlü Kantar, Tolga Doğan, Semra Taş, Bedriye Açıkgöz Yıldız, Gamze Serin Özel, Ceren Mordağ Çiçek, Ahmet Ali Kantar, Burcu Yapar Taşköylü, Atike Gökçen Demiray, Tarık Şengöz, Özgür Tanrıverdi, Arzu Yaren, Gamze Gököz Doğu
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	MDPI AG 2026-06-01
Seri Bilgileri:	Diagnostics
Konular:	T-DM1 HER2-positive metastatic breast cancer inflammatory indices neutrophil-to-lymphocyte ratio CRP/albumin ratio real-world outcomes
Online Erişim:	https://www.mdpi.com/2075-4418/16/11/1746
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!

Prognostic Role of Inflammatory Indices and Real-World Outcomes in HER2-Positive Metastatic Breast Cancer Treated with Trastuzumab Emtansine

Benzer Materyaller